» Articles » PMID: 37840797

Improving Mental Well-being in Psychocardiology-a Feasibility Trial for a Non-blended Web Application As a Brief Metacognitive-based Intervention in Cardiovascular Disease Patients

Abstract

Background: Many patients with cardiovascular disease also show a high comorbidity of mental disorders, especially such as anxiety and depression. This is, in turn, associated with a decrease in the quality of life. Psychocardiological treatment options are currently limited. Hence, there is a need for novel and accessible psychological help. Recently, we demonstrated that a brief face-to-face metacognitive therapy (MCT) based intervention is promising in treating anxiety and depression. Here, we aim to translate the face-to-face approach into digital application and explore the feasibility of this approach.

Methods: We translated a validated brief psychocardiological intervention into a novel non-blended web app. The data of 18 patients suffering from various cardiac conditions but without diagnosed mental illness were analyzed after using the web app over a two-week period in a feasibility trial. The aim was whether a non-blended web app based MCT approach is feasible in the group of cardiovascular patients with cardiovascular disease.

Results: Overall, patients were able to use the web app and rated it as satisfactory and beneficial. In addition, there was first indication that using the app improved the cardiac patients' subjectively perceived health and reduced their anxiety. Therefore, the approach seems feasible for a future randomized controlled trial.

Conclusion: Applying a metacognitive-based brief intervention via a non-blended web app seems to show good acceptance and feasibility in a small target group of patients with CVD. Future studies should further develop, improve and validate digital psychotherapy approaches, especially in patient groups with a lack of access to standard psychotherapeutic care.

References
1.
Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D . European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022; 43(8):716-799. DOI: 10.1093/eurheartj/ehab892. View

2.
Palacios J, Khondoker M, Mann A, Tylee A, Hotopf M . Depression and anxiety symptom trajectories in coronary heart disease: Associations with measures of disability and impact on 3-year health care costs. J Psychosom Res. 2017; 104:1-8. DOI: 10.1016/j.jpsychores.2017.10.015. View

3.
McPhillips R, Salmon P, Wells A, Fisher P . Qualitative Analysis of Emotional Distress in Cardiac Patients From the Perspectives of Cognitive Behavioral and Metacognitive Theories: Why Might Cognitive Behavioral Therapy Have Limited Benefit, and Might Metacognitive Therapy Be More Effective?. Front Psychol. 2019; 9:2288. PMC: 6328488. DOI: 10.3389/fpsyg.2018.02288. View

4.
Nahum-Shani I, Smith S, Spring B, Collins L, Witkiewitz K, Tewari A . Just-in-Time Adaptive Interventions (JITAIs) in Mobile Health: Key Components and Design Principles for Ongoing Health Behavior Support. Ann Behav Med. 2016; 52(6):446-462. PMC: 5364076. DOI: 10.1007/s12160-016-9830-8. View

5.
Pasarelu C, Andersson G, Nordgren L, Dobrean A . Internet-delivered transdiagnostic and tailored cognitive behavioral therapy for anxiety and depression: a systematic review and meta-analysis of randomized controlled trials. Cogn Behav Ther. 2016; 46(1):1-28. DOI: 10.1080/16506073.2016.1231219. View